You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (2) |
Back to Search
Improving prescriber adherence to commissioning criteria when prescribing high-cost SACT in lung cancer.
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPR-031
- By: HIRANI, Seetal (University College London Hospital, Cancer Services, United Kingdom)
- Co-author(s): Seetal Hirani: Cancer Services, University College London Hospital, London, United Kingdom
Hector Mateo-Carrasco: Cancer Services, University College London Hospital, London, United Kingdom;Cancer Services, University College London Hospital, London, United Kingdom - Abstract:
Background
In the UK, funding of high-cost systemic anti-cancer treatments (SACT) falling outside the standard payment-by-results reimbursement system is managed and approved using a web-based system (Blueteq®). Absence of relevant funding prior to SACT administration may have considerable cost implications and/or result in treatment delays.Purpos..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026